These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6307193)

  • 1. Behavioral studies of shaking behavior induced by thyrotropin-releasing hormone and morphine withdrawal in rats.
    Yamada K; Matsuki J; Ushijima I; Inoue T; Furukawa T
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):24-33. PubMed ID: 6307193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological aspects of shaking behavior produced by TRH, AG-3-5, and morphine withdrawal.
    Wei ET
    Fed Proc; 1981 Apr; 40(5):1491-6. PubMed ID: 6260535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RX 336-M, a new chemical tool in the analysis of the quasi-morphine withdrawal syndrome.
    Cowan A
    Fed Proc; 1981 Apr; 40(5):1497-501. PubMed ID: 6783443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potentiation of morphine-withdrawal jumping by clonidine is antagonized by m-chlorophenylpiperazine and not by haloperidol.
    van der Laan JW; Hillen FC
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):45-55. PubMed ID: 2879519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thyrotropin-releasing hormone (TRH)-induced hyperthermia and behavioral excitation in rabbits.
    Horita A; Carino MA
    Psychopharmacol Commun; 1975; 1(4):403-14. PubMed ID: 817376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of both opiate and catecholaminergic receptors in the behavioural excitation provoked by thyrotropin-releasing hormone: comparisons with amphetamine.
    Lin MT; Chan HK; Chen CF; Teh GW
    Neuropharmacology; 1983 Apr; 22(4):463-9. PubMed ID: 6304565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological analysis of shaking behavior induced by enkephalins, thyrotropin-releasing hormone or serotonin in rats: evidence for different mechanisms.
    Drust EG; Connor JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):148-54. PubMed ID: 6401333
    [No Abstract]   [Full Text] [Related]  

  • 8. Wet-dog body shaking induced by electrical stimulation of hippocampus in the intact and reserpinized rat.
    Yamada K; Matsuki J; Furukawa T
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):29-37. PubMed ID: 6844737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thyrotropin-releasing hormone analogues on body shaking and prolactin levels in estrogen-primed and nonprimed rats.
    Yamada K; Kumagai M; Nagashima M; Matsuo N; Furukawa T
    Arch Int Pharmacodyn Ther; 1989; 297():235-46. PubMed ID: 2499289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The potential antinarcotic effects of guanfacine].
    Marusov IV; Bogdanov EG; Marusova IB
    Eksp Klin Farmakol; 1996; 59(3):24-7. PubMed ID: 8974578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The modulating effect of the thyrotropin-releasing hormone on genetically induced mechanisms of morphine sensitivity].
    Borisova EV; Sudakov SK
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1995; 45(6):1174-81. PubMed ID: 8585307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of YM-14673, a new TRH analogue, on responses to morphine in rodents.
    Yamamoto M; Shimizu M; Ozawa Y
    Arch Int Pharmacodyn Ther; 1989; 300():29-36. PubMed ID: 2515820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-administration associations and withdrawal symptoms: morphine-elicited morphine withdrawal.
    McDonald RV; Siegel S
    Exp Clin Psychopharmacol; 2004 Feb; 12(1):3-11. PubMed ID: 14769091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on thyrotrophin releasing hormone analgesia.
    Ramaswamy S; Bapna JS
    Methods Find Exp Clin Pharmacol; 1987 Aug; 9(8):485-8. PubMed ID: 3121963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin releasing hormone-induced potentiation of spinal monosynaptic reflex in rats in vitro.
    Deshpande SB; Warnick JE
    Indian J Exp Biol; 1993 Feb; 31(2):112-5. PubMed ID: 8500826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central sites of naloxone-precipitated shaking in the anesthetized, morphine-dependent rat.
    Wei E; Sigel SS; Loh HH; Way EL
    J Pharmacol Exp Ther; 1975 Dec; 195(3):480-7. PubMed ID: 1238555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The action of low doses of bromocryptin in experimental morphine abstinence in rats].
    Stanishevskaia AV; Khristoliubova NA; Vekshina NL; Varfolomeev SO; Anokhina IP
    Farmakol Toksikol; 1991; 54(3):15-7. PubMed ID: 1655521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of behavioral tolerance by repeated treatment with taltirelin hydrate, a thyrotropin-releasing hormone analog, in rats.
    Asai H; Asahi T; Yamamura M; Yamauchi-Kohno R; Saito A
    Pharmacol Biochem Behav; 2005 Dec; 82(4):646-51. PubMed ID: 16368129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral effects of thyrotropin releasing hormone in frontal decorticated rats.
    Katsuura G; Yoshikawa K; Itoh S; Hsiao S
    Peptides; 1984; 5(5):899-903. PubMed ID: 6438612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of behaviorally active doses of thyrotropin-releasing hormone and its analog MK-771 on dopaminergic neuronal systems in the brain of the rat.
    Yamada K; Demarest KT; Moore KE
    Neuropharmacology; 1984 Jul; 23(7A):735-9. PubMed ID: 6433220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.